No products in the cart.
Introduction In recent years, psilocybin—the active compound in magic mushrooms—has moved from the fringes of counterculture into the mainstream of scientific research. Among the most exciting developments is CYB003, a chemically modified version of psilocybin that’s showing remarkable promise in clinical trials for major depressive disorder (MDD). As we navigate a global mental health crisis, […]